Fibrates are commonly prescribed for hypertriglyceridemia but also lower low-density lipoprotein cholesterol (LDL-C) and raise high-density lipoprotein cholesterol (HDL-C). Large inter-individual variation in lipid response suggests that some persons may benefit more than others and genetic studies could help identify those persons
Abstract Background Fenofibrate (Fb) is a known treatment for elevated triglyceride (TG) levels. The...
BACKGROUND: Blood lipid levels including low-density lipoprotein cholesterol (LDL-C), high-density l...
Cardiovascular disease (CVD) is a major public health concern in the U.S., and is the leading cause ...
Fibrates are commonly prescribed for hypertriglyceridemia but also lower low-density lipoprotein cho...
<div><p>A recent large-scale meta-analysis of genome-wide studies has identified 95 loci, 59 of them...
Our understanding of genetic influences on the response of lipids to specific interventions is limit...
BACKGROUND: Use of anti-hyperlipidemic medications compromises genetic analysis because of altered l...
Abstract Background Use of anti-hyperlipidemic medications compromises genetic analysis because of a...
Genetic studies might provide new insights into the biological mechanisms underlying lipid metabolis...
We review the main findings from genome-wide association studies (GWAS) for levels of HDL-cholestero...
Serum concentrations of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density...
For the past five years, genome-wide association studies (GWAS) have identified hundreds of common v...
Abstract In this paper we analyzed whole-genome genetic information provided by GAW20 from the Genet...
BACKGROUND: Increased postprandial lipid (PPL) response to dietary fat intake is a heritable risk fa...
BackgroundFenofibrate (Fb) is a known treatment for elevated triglyceride (TG) levels. The Genetics ...
Abstract Background Fenofibrate (Fb) is a known treatment for elevated triglyceride (TG) levels. The...
BACKGROUND: Blood lipid levels including low-density lipoprotein cholesterol (LDL-C), high-density l...
Cardiovascular disease (CVD) is a major public health concern in the U.S., and is the leading cause ...
Fibrates are commonly prescribed for hypertriglyceridemia but also lower low-density lipoprotein cho...
<div><p>A recent large-scale meta-analysis of genome-wide studies has identified 95 loci, 59 of them...
Our understanding of genetic influences on the response of lipids to specific interventions is limit...
BACKGROUND: Use of anti-hyperlipidemic medications compromises genetic analysis because of altered l...
Abstract Background Use of anti-hyperlipidemic medications compromises genetic analysis because of a...
Genetic studies might provide new insights into the biological mechanisms underlying lipid metabolis...
We review the main findings from genome-wide association studies (GWAS) for levels of HDL-cholestero...
Serum concentrations of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density...
For the past five years, genome-wide association studies (GWAS) have identified hundreds of common v...
Abstract In this paper we analyzed whole-genome genetic information provided by GAW20 from the Genet...
BACKGROUND: Increased postprandial lipid (PPL) response to dietary fat intake is a heritable risk fa...
BackgroundFenofibrate (Fb) is a known treatment for elevated triglyceride (TG) levels. The Genetics ...
Abstract Background Fenofibrate (Fb) is a known treatment for elevated triglyceride (TG) levels. The...
BACKGROUND: Blood lipid levels including low-density lipoprotein cholesterol (LDL-C), high-density l...
Cardiovascular disease (CVD) is a major public health concern in the U.S., and is the leading cause ...